ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

New ACS Program Honors Mary Lasker

August 31, 1984

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003

In Brief: Koprowski, Niederhuber, Engstrom Chair DCE, DCT, DCPC BSCs; Roentgen Ray Officers Named

June 19, 1987

In the States: Arizona Approves Legislation on Patient Care Costs in Trials

May 5, 2000